| Business Summary | | Bio-Vascular,
Inc.
is
a
diversified
medical
device
company,
engaged
in
developing,
manufacturing
and
marketing
products
to
improve
the
quality
of
human
life.
The
Company
operates
through
two
business
units.
The
Branded
Medical
Device
business
includes
branded
implantable
biomaterials,
surgical
productivity
tools
and
licensed
and
distributed
products
for
use
in
critical
surgeries,
including
bariatric
(stomach
and
intestines),
thoracic
(chest
and
lungs),
cardiac
(heart),
neurosurgical
(brain
and
spine),
and
vascular
(arteries
and
veins)
surgeries.
Branded
Medical
Devices
are
manufactured
using
the
Company's
patented
and
proprietary
technologies.
Jerneen
Micro
Medical
Technologies,
a
wholly
onwed
subsidiary,
custom
designs,
engineers
and
manufactures
precision
micro
wire
components
that
are
used
primarily
in
implantable
interventional
cardiovascular
and
neurological
devices,
such
as
pacemakers,
defibrillators
and
neuro
and
spinal
electro-stimulation
devices. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Bio-Vascular,
Inc.
develops,
manufactures
and
markets
branded
proprietary
and
patented
specialty
medical
products
for
use
in
thoracic,
cardiac,
neuro,
vascular
and
ophthalmic
surgery.
For
the
six
months
ended
4/30/01,
revenues
rose
37%
to
$13.4
million.
Net
income
totaled
$780
thousand
vs.
a
loss
of
$167
thousand.
Revenues
reflect
an
increase
in
domestic
Peri-Strips
sales
and
Micro
Medical
Technologies
segment
sales.
Earnings
also
reflects
lower
personnel
expenses. Recent Earnings Announcement For
the
3
months
ended
07/31/2001,
revenues
were
7,087;
after
tax
earnings
were
503. (Preliminary; reported in thousands of dollars.) | More
from
Market Guide: Significant
Developments |
| | | | FY2000
Compensation | | Pay | Exer | |
| Timothy Scanlan, 54 Chairman | -- | -- | M. Karen Gilles, 58 Pres,
CEO | $256K | $11K | Connie Magnuson, 39 VP
of Fin., CFO and Corp. Sec. | 152K | -- | Evan Johnston, 40 VP-Operations | -- | -- | David Buche, 39 VP
of Marketing and Sales | 162K | -- | Dollar
amounts are as of 31-Oct-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|